Deep Sharma

Adley Labs Ltd

Adley Group is focused on increasing momentum in Oncology Business in its key markets through organic and inorganic growth routes. In Adley Family, "BETA Drugs' is a newly acquired dedicated Oncology Formulation facility with latest technology which is adhering in PICS & EU-GMP Norms. BETA Drugs is a fully automated facility without human involvement. ADLEY Group is emhancing international Presence with effective rehulatory team for dossier compilation & Submission as required by emerging, developing and developed economies. What's new in Adley Group? Adley Bulk Drugs and Research is a a newly constructed facility specialize in Oncology API manufacturing and research in the northern region of India with modern highly sophisticated machineries and infrastructure as per latest USFDA & EU_GMP norms. Strong R&D and quality departments are jointly developing latest generation Oncology API's in a phase wise manner as per international market requirement. Now we have independently become successful in developing different NDDS technologies. These new growth areas will add significant depth to the existing product pipeline. The Adley group is very much positive to increase the revenue generationm, economies of scale and profitability of the while group. We are committed to concology development through new creation, catering the benefit to the society and serving the medical fraternities & business associates